Pharmagreen Biotech Inc.
PHBI · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $0 | $4 | $8 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $1 | $4 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.7% | – | – | – |
| Gross Profit | $0 | -$0 | $0 | -$0 |
| % Margin | 50.9% | -215% | – | – |
| EBITDA | -$1 | $0 | $0 | -$4 |
| % Margin | -28,480.5% | 879.4% | – | – |
| Net Income | -$1 | -$1 | -$1 | -$5 |
| % Margin | -29,442.8% | -18,979.3% | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.002 | -0.015 |
| % Growth | -25% | 45.5% | 85.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |